Physician profile
David L Cornell
NPI 1962456871
$804.06
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $83.99 · 2021: $48.26 · 2022: $88.36 · 2023: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $157.75 | 2019 | |
| Polarityte, INC. | $94.12 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.02 | 2019 | |
| Kerecis Limited | $65.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kci USA, INC. | $56.96 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $54.72 | 2019-2021 | |
| Melinta Therapeutics, LLC | $35.38 | 2019-2020 | |
| Haemonetics Corporation | $34.64 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.05 | 2022-2023 | Andexxa |
| Csl Behring | $30.61 | 2023 | Kcentra |
| Acera Surgical, INC. | $26.28 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.17 | 2022 | |
| Integra Lifesciences Corporation | $23.66 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $23.13 | 2022 | |
| Braintree Laboratories, INC. | $20.33 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $17.66 | 2023 | Recell |
| Mallinckrodt Hospital Products INC. | $15.20 | 2020 | |
| Biodelivery Sciences International, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cornell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.